发明名称 TREATING OBESITY WITH SELECTIVE ANDROGEN RECEPTOR MODULATORS
摘要 This invention relates to the prevention and treatment of obesity. More particularly, this invention relates to a method of: a) treating, preventing, suppressing, inhibiting, or reducing obesity; b) promoting, increasing or facilitating weight loss; c) decreasing, suppressing, inhibiting or reducing appetite; d) altering the body composition, e) altering lean body mass or fat free body mass, f) converting fat to lean muscle; g) treating, preventing, suppressing, inhibiting, or reducing an obesity-associated metabolic disorder, for example hypertension, osteoarthritis, Type II diabetes mellitus, increased blood pressure, stroke, or heart disease; h) decreasing, suppressing, inhibiting or reducing adipogenesis; i) altering stem cell differentiation; and/or j) altering the level of leptin; comprising administering a therapeutically effective amount of a selective androgen receptor modulator and/or its analog, derivative, isomer, metabolite, pharmaceutically acceptable salt, pharmaceutical product, hydrate, N-oxide, prodrug, polymorph, crystal, or any combination thereof, as described herein.
申请公布号 WO2004034978(A3) 申请公布日期 2004.07.15
申请号 WO2003US32509 申请日期 2003.10.14
申请人 GTX, INC.;DALTON, JAMES, T.;MILLER, DUANE, D.;STEINER, MITCHELL, S.;VEVERKA, KAREN, A. 发明人 DALTON, JAMES, T.;MILLER, DUANE, D.;STEINER, MITCHELL, S.;VEVERKA, KAREN, A.
分类号 A61K31/165;A61K31/405;A61K31/4706;A61K31/675 主分类号 A61K31/165
代理机构 代理人
主权项
地址